Innate autoimmunity

Advances in Immunology

Volumn 86, Issue , 2005, Pages 137-157

  Carroll, Michael C ^a   Holers, V Michael ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; IMMUNOGLOBULIN M; RAG1 PROTEIN;

ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD FLOW; CARDIOPULMONARY BYPASS; CELLULAR IMMUNITY; FETUS WASTAGE; FOLLOW UP; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; ISCHEMIA; KIDNEY ISCHEMIA; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SKELETAL MUSCLE; WILD TYPE;

EID: 13444270722     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(04)86004-8     Document Type: Article

References (71)

1. Aderem A., Underhill D.M. Mechanism of phagocytosis in macrophages. Annu. Rev. Immunol. 17:1999;593-623
2. Arumugam T.V., Shiels I.A., Strachan A.J., Abbenante G., Fairlie D.P., Taylor S.M. A small molecule C5a receptor antagonist protects kidneys from ischemia-reperfusion injury in rats. Kidney Int. 63:2003;134-142
3. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science. 300:2003;1524-1525
4. Baumgarth N., Herman O., Jager G., Brown L., Herzenberg L., Herzenbergh L. B1 and B2 cell-derived immunoglobulin M antibodies are non-redundant components of the protective response to influenza virus infection. J. Exp. Med. 192:2000;271-280
5. Boes M., Prodeus A., Schmidt T., Carroll M.C., Chen J. A critical role of natural IgM in immediate response against systemic bacterial infection. J. Exp. Med. 188:1998;2381-2386
6. Briaud S.A., Ding Z.M., Michael L.H., Entman M.L., Daniel S., Ballantyne C.M. Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H60-H67
7. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:1998;545-568
8. Cauchetaux S.M., Kanellopoulos-Langevin C., Ojcius D.M. At the innate frontiers between mother and fetus: Linking abortion with complement activation. Immunity. 18:2003;169-172
9. Chai P.J., Nassar R., Oakeley A.E., Craig D.M., Quick G. Jr., Jaggers J., Sanders S.P., Ungerleider R.M., Anderson P.A. Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage. Circulation. 101:2000;541-546
10. Cotran R.S., Kumar V., Robbins S.L. "Pathologic Basis of Disease." 1994;W. B. Saunders, Philadelphia, PA
11. de Vries B., Kohl J., Leclerq W.K.G., Wolfs T.G.A.M., van Bijnen A.A.J.H.M., Heeringa P., Buurman W.A. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J. Immunol. 170:2003a;3883-3889
12. de Vries B., Matthijsen R.A., Wolfs T.G.A.M., van Bijnen A.A.J.H.M., Heeringa P., Buurman W.A. Inhibition of complement factor 5 protects against renal ischemia-reperfusion injury: Inhibition of late apoptosis and inflammation. Transplantation. 75:2003b;375-382
13. Epstein J., Eichbaum Q., Sheriff S., Ezekowitz R. The collectins in innate immunity. Curr. Opin. Immunol. 8:1996;29-35
14. Espinosa G., Cervera R., Font J., Schoenfeld Y. Antiphospholipid syndrome: Pathogenic mechanisms. Autoimmun. Rev. 2:2003;86-93
15. Fearon D.T., Carter R.H. The CD19/CR2/TAPA-1 Complex of B lymphocytes: Linking natural to acquired immunity. Annu. Rev. Immunol. 13:1995;127-149
16. Fleming S.D., Shea-Donohue T., Guthridge J.M., Kulik L., Waldschmidt T.J., Gipson M.G., Tsokos G.C., Holers V.M. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169:2002;2126-2133
17. Foley S., Li B., Dehoff M., Molina H., Holers V.M. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Eur. J. Immunol. 23:1993;1381-1384
18. Girardi G., Berman J., Redecha P., Spruce L., Kraus D.M., Hollman T.J., Casali P., Wetsel R.A., Lambris J.D., Holers V.M., Salmon J.E. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 112:2003;1644-1654
19. Hannan J., Young K., Szakonyi G., Overduin M.J., Perkins S.J., Chen X., Holers V.M. Structure of complement receptor (CR) 2 and CR2-C3d complexes. Biochem. Soc. Trans. 30:2002;983-989
20. + B cells. Immunol. Rev. 137:1994;91
21. Hill J., Lindsay T.F., Ortiz F., Yeh C.G., Hechtman H.B., Moore F.D. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J. Immunol. 149:1992;1723-1730
22. Holers V.M. Complement. Rich R. "Principles and Practices of Clinical Immunology" 2001;21.1-21.8 Mosby, St. Louis, MO
23. Holers V.M., Girardi G., Mo L., Guthridge J.M., Molina H., Pierangelli S., Espinola R., Xiaowei L.E., Mao D., Vialpando C.J., Salmon J.E. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195:2002;211-220
24. Huang J., Kim L., Mealey R., Marsh H., Zhang Y., Tenner A., Connolly E., Pinsky D. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science. 285:1999;595-599
25. Ikematsu W., Luan F.L., LaRosa L., Beltrami B., Nicoletti F., Buyon J.P., Meroni P.L., Casali P. Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arth. Rheum. 41:1998;1026-1039
26. Janeway C.A. Jr., Medzhitov R. Lipoproteins take their toll on the host. Curr. Biol. 9:1999;R879-R882
27. Kantor A.B., Merrill C.E., Herzenberg L.A., Hillson J.L. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J. Immunol. 158:1997;1175-1186
28. Kim Y.U., Kinoshita T., Molina H., Hourcade D., Seya T., Wagner L.M., Holers V.M. Mouse complement regulatory protein Crry/p65 utilizes the specific mechanisms of both decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181:1995;151-159
29. Levy E.M., Viscoli C.M., Horwitz R.I. The effects of acute renal failure on mortality: A cohort analysis. JAMA. 275:1996;1489-1494
30. Li B., Sallee C., Dehoff M., Foley S., Molina H., Holers V.M. Mouse Crry/p65: Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151:1993;4295-4305
31. Li C., Jackson R. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 282:2002;C227-C241
32. Liano F., Junco E., Pasqual J., Madero R., Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings: The madrid acute renal failure study group. Kidney Int. 66:1998;S16-S24
33. Linton S.M., Morgan B.P. Complement activation and inhibition in experimental models of arthritis. Mol. Immunol. 36:1999;905-914
34. Liszewski M.K., Farries T.C., Lublin D.M., Rooney I.A., Atkinson J.P. Control of the complement system. Adv. Immunol. 61:1996;201-283
35. + release and cellular efflux in ischemic and apoptotic neuronal death. J. Neurochem. 86:2003;966-979
36. Malynn B., Yancopoulos G., Barth J., Bona C., Alt F. Biased expression of JH-proximal VH genes occurs in the newly generated repertoire of neonatal and adult mice. J. Exp. Med. 171:1990;843-859
37. Mao D., Wu X., Deppong C., Friend L.D., Dolecki G.J., Nelson D.M., Molina H. Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity. 19:2003;813-822
38. Matsumoto M., Fukuda H., Circolo A., Goellner J., Strauss-Schoenberger J., Wang X., Fujita S., Hidvegi T., Chaplin D.D., Colten H.R. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. USA. 94:1997;8720-8724
39. McIntyre J.A., Wagenknecht D.R., Faulk W.P. Antiphospholipid antibodies: Discovery, definitions, detection and disease. Prog. Lipid Res. 42:2003;176-237
40. Mellor A.L., Sivakumar J., Chandler P., Smith K., Molina H., Mao D., Munn D.H. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2:2001;64-68
41. Miwa T., Sun X., Ohta R., Okada N., Harris C.L., Morgan B.P., Song W.C. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity. Immunology. 104:2001;207-214
42. Mizuno M., Nishikawa K., Spiller O.B., Morgan B.P., Okada N., Okada H., Matsuo S. Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats. Arthritis Rheum. 44:2001;2425-2434
43. Molina H., Wong W., Kinoshita T., Brenner C., Foley S., Holers V.M. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologs of human CR1. J. Exp. Med. 175:1992;121-129
44. Muller-Eberhard H.J. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:1988;321-347
45. Nath K.A., Hostetter M.K., Hostetter T.H. Pathophysiology of chronic tubulo-interstitial disease in rats: Interactions of dietary acid load, ammonia, and complement component C3. J. Clin. Invest. 76:1985;667-675
46. Nishimura J., Smith C.A., Phillips K.L., Ware R.E., Rosse W.F. Paroxysmal nocturnal hemoglobinuria: Molecular pathogenesis and molecular therapeutic approaches. Hematopathol. Mol. Hematol. 36:1998;119-146
47. Ochsenbein A., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., Zinkernagel R. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 286:1999;2156-2159
48. Park P., Haas M., Cunningham P.N., Bao L., Alexander J.J., Quigg R.J. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am. J. Physiol. Renal Physiol. 282:2002;F352-F357
49. Qin X., Miwa T., Aktas H., Gao M., Lee C., Qian Y.M., Morton C.C., Shahsafaei A., Song W.C., Halperin J.A. Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b. Mamm. Genome. 12:2001;582-589
50. Rand J.H. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: A thrombogenic mechanism for the antiphospholipid syndrome. J. Autoimmun. 15:2000;107-111
51. Ratnoff W.D., Fearon D.T., Austen K.F. The role of antibody in the activation of the alternative complement pathway. Springer Semm. Immunopathol. 6:1983;361-371
52. Reid K.B.M., Porter R.R. The proteolytic activation systems of complement. Annu. Rev. Biochem. 50:1981;433-464
53. Reid R.R., Woodcock S., Shimabukuro-Vornhagen A., Austen W.G. Jr., Kobzik L., Zhang M., Hechtman H.B., Moore F.D. Jr., Carroll M.C. Functional activity of natural antibody is altered in Cr2-deficient mice. J. Immunol. 169:2002;5433-5440
54. Richards A., Goodship J.A., Goodship T.H. The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Curr. Opin. Nephrol. Hypertens. 11:2002;431-435
55. Richards A., Kemp E.J., Liszewski M.K., Goodship J.A., Lampe A.K., Decorte R., Muslumanoglu M.H., Kavukcu S., Filler G., Pirson Y., Wen L.S., Atkinson J.P., Goodship T.H. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl. Acad. Sci. USA. 100:2003;12966-12971
56. Seidl K., Wilshire J., MacKenzie J., Kantor A., Herzenberg L., Herzenberg L. Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites. Proc. Natl. Acad. Sci. USA. 96:1999;2262-2267
57. Sheridan A.M., Bonventre J.V. Pathophysiology of ischemic acute renal failure. Contrib. Nephrol. 132:2000;7-21
58. Simpson R., Alon R., Kobzik L., Valeri C., Shepro D., Hechtman H. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann. Surg. 218:1993;444-453
59. Sporer H., Lang F., Oberleithner H., Greger R., Deetjen P. Inefficacy of bicarbonate infusions on the course of postischaemic acute renal failure in the rat. Eur. J. Clin. Invest. 11:1981;311-315
60. Stahl G.L., Xu Y., Hao L., Miller M., Buras J.A., Fung M., Zhao H. Role for the alternative complement pathway in ischemia/reperfusion injury. Am. J. Pathol. 162:2003;449-455
61. Tatsumi T., Shiraishi J., Keira N., Akashi K., Mano A., Yamanaka S., Matoba S., Fushiki S., Fliss H., Nakagawa M. Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc. Res. 59:2003;428-440
62. Thadhani R., Pasqual M., Bonventre J.V. Acute renal failure. N. Engl. J. Med. 334:1996;1448-1460
63. Thurman J.M., Ljubanovic C., Edelstein C.L., Gilkeson G.S., Holers V.M. Lack of a functional alternative pathway ameliorates ischemic acute renal failure in mice. J. Immunol. 170:2003;1517-1523
64. Thurman J.M., Kraus D.M., Girardi G., Hourcade D.E., Kang H.-J., Royer P.A., Mitchell L.M., Giclas P.C., Salmon J.E., Gilkerson G.S., Holers V.M. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. Mol. Immunol. 42:2005;87-97
65. Vabulas R.M., Ahmad-Nejad P., Ghose S., Kirschning C.J., Issels R.D., Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277:2002;15107-15112
66. Weiser M., Williams J., Moore F., Kobzik L., Ma M., Hechtman H., Carroll M. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183:1996;2343-2348
67. Weisman H.F., Bartow T., Leppo M.K., Marsh H.C., Carson G.R., Concino M.F., Boyle M.P., Roux K.H., Weisfeldt M.L., Fearon D.T. Souble human complement receptor type I: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 249:1990;146-151
68. Williams J.P., Moore F.D., Kobzik L., Carroll M.C., Hechtman H.B. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86:1999;938-942
69. Xu C., Mao D., Holers V.M., Balanca B., Cheng A.M., Molina H. A critical role for murine complement regulator Crry in fetomaternal tolerance. Science. 99:2000;498-501
70. Zhang M., Austen W.G. Jr., Chiu I., Alicot E.M., Hung R., Ma M., Verna N., Xu M., Hechtman H.B., Moore F.D. Jr., Carroll M.C. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA. 101:2004;3886-3891
71. Zhou W., Farrar C.A., Abe K., Pratt J.R., Marsh J.E., Wang Y., Stahl G.L., Sacks S.H. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J. Clin. Invest. 105:2000;1363-1371